Treatment of Shoulder Osteoarthritis
NCT05657587 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2023-02-27
Summary
The purpose of this study is to learn if pain can be relieved by delivering small amounts of electricity ("electrical stimulation") to the nerves relaying sensory information to the shoulder. This study will use a device called Sprint PNS system. PNS stands for Peripheral Nerve Stimulation. This device is cleared by the FDA for up to 60 days of use for relief of chronic or acute pain.
Conditions
- Chronic Shoulder Pain
Interventions
- DEVICE
-
SPRINT PNS
Each subject will have 2 leads placed for 60 days. The Sprint system delivers mild electrical stimulation to the shoulder. The Sprint system includes up to two leads (small wires) that are placed through your skin in your shoulder. The leads attach to devices worn on your body that delivers stimulation (stimulators).
Sponsors & Collaborators
-
Gramercy Pain Center
lead OTHER
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-04-01
- Primary Completion
- 2023-12-31
- Completion
- 2023-12-31
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Clinical Study Of a Micro-Implantable Pulse Generator For The Treatment of Peripheral Neuropathic Pain
NCT05287373 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Mechanisms of Stimulation for Pain Alleviation
NCT06741579 ·Status: RECRUITING ·Phase: PHASE3
-
Clinical Study of a Micro-Implantable Pulse Generator for the Treatment of Peripheral Neuropathic Pain (COMFORT 2)
NCT05870124 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Retrospective-Prospective PNS Study
NCT06845631 ·Status: RECRUITING ·Phase: NA
-
A Study of Tanezumab in Adults With Chronic Low Back Pain
NCT00876187 ·Status: COMPLETED ·Phase: PHASE2
-
Retrospective PNS Study
NCT06832449 ·Status: ACTIVE_NOT_RECRUITING
-
Bioness® StimRouter™ Neuromodulation System for Chronic Pain Therapy
NCT01592344 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness of Magnetic Peripheral Nerve Stimulation for the Treatment of Chemotherapy Induced Neuropathy
NCT05935956 ·Status: COMPLETED
-
Short Duration Electrical Stimulation to Improve Outcomes After Cubital Tunnel Release (SELECT) Trial
NCT05980767 ·Status: RECRUITING ·Phase: NA
-
Scrambler Therapy for the Reduction of Chemotherapy-Induced Neuropathic Pain
NCT04239976 ·Status: COMPLETED ·Phase: NA
-
The Study of GW493838, an Adenosine A1 Agonist, in Peripheral Neuropathic Pain
NCT00376454 ·Status: COMPLETED ·Phase: PHASE2
-
SCS for Patient With Painful Diabetic Neuropathy and Peripheral Arterial Disease
NCT06480786 ·Status: RECRUITING ·Phase: NA
-
Clinical Trial for Idiopathic Hip Pain Using Peripheral Nerve Stimulation
NCT05074329 ·Status: UNKNOWN ·Phase: NA
-
Pilot Study: Impact of Biomarker-Guided Dietary Supplementation on Quality-of-Life Measures in Subjects With Chronic Pain
NCT06247813 ·Status: RECRUITING ·Phase: PHASE2
-
Intermittent Dosing of Dorsal Root Ganglion Stimulation as an Alternate Paradigm to Continuous Low-Frequency Therapy
NCT04909138 ·Status: RECRUITING ·Phase: NA
-
Simultaneous Engagement of Networks for Alleviating Pain (SENAP)
NCT07057206 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
BlueWind Reprieve System for the Treatment of PNP
NCT02209896 ·Status: COMPLETED ·Phase: NA
-
Electrical Stimulation Therapy Using the MC5-A Scrambler in Reducing Peripheral Neuropathy Caused by Chemotherapy
NCT00952848 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Transdermal Fentanyl for Chronic Neuropathic Pain
NCT00181246 ·Status: COMPLETED ·Phase: NA
-
Treatment for Painful Diabetic Neuropathy
NCT05937984 ·Status: UNKNOWN ·Phase: NA
-
MC5-A Scrambler Therapy in Reducing Peripheral Neuropathy Caused by Chemotherapy
NCT01290224 ·Status: COMPLETED ·Phase: PHASE2
-
Burst Optimized Stimulation Study
NCT02896361 ·Status: COMPLETED ·Phase: NA
-
A Study of Single Dose Pain Therapy in Patients With Painful Diabetic Neuropathy (0000-115)
NCT00837941 ·Status: WITHDRAWN ·Phase: PHASE2
-
Safety and Efficacy Study of ADL5859 in Participants With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
NCT00603265 ·Status: COMPLETED ·Phase: PHASE2
-
Scrambler Therapy With Duloxetine-based Usual Care vs Duloxetine-based Usual Care for Chemotherapy-induced Peripheral Neuropathy.
NCT06914557 ·Status: RECRUITING ·Phase: PHASE2